Study links continuous glucose monitoring to better glycemic control

11/27/2011 | PhysiciansBriefing.com

Intermittent real-time continuous glucose monitoring for three months improved and sustained glycemic control better than self-monitoring in patients with type 2 diabetes who were not on prandial insulin treatment, researchers reported in Diabetes Care. Researchers noted a greater decline in hemoglobin A1C levels, without the need for intensified medications, in those who had RT-CGM compared with those in the self-monitoring group.

View Full Article in:

PhysiciansBriefing.com

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY